• Nenhum resultado encontrado

Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.

N/A
N/A
Protected

Academic year: 2017

Share "Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation."

Copied!
10
0
0

Texto

Loading

Imagem

Figure 1. Ovarian Morphology of control and IR/LepR POMC females. A-E. Ovarian sections throughout the ovaries of individual control and IR/LepR POMC females were examined for follicle types shown, n = 13–17
Figure 3. Increased fat mass and intra-abdominal adipocyte hypertrophy in IR/LepR POMC mice
Figure 5. IR/LepR POMC females are hyperglycemic and show hyperglycemia during pregnancy

Referências

Documentos relacionados

Se considerarmos o momento improvisacional como impulso-intuitivo, sensível e o estrutural como racional pois implica capacidade de repetição rigorosa, nos

As there is controversy about the prevalence of hypertension in patients with polycystic ovary syndrome (PCOS) and, up to the present moment, no studies have evaluated the impact

Only limited information is available con- cerning the histologic distribution of gluca- gon receptors in vivo in liver parenchymal cells (105,106), intestinal smooth muscle

 Reproductive Hormone Levels and Anthro- pometry in Postmenopausal Women with Polycystic Ovary Syndrome (PCOS): A 21-Year Follow-Up Study of Women Diagnosed with PCOS Around

The relationship between leptin, adiponectin, ghrelin, homocysteine, insulin resistance and other biochemical factors in women with polycystic ovary syndrome (PCOS) is

HCD compared to SD induced also local inflammation demonstrated by adipocyte hypertrophy and infiltration of T-lymphocytes in abdominal white adipose tissue, activation

The pathogenesis of PCOS is not fully elucidated, but four aspects seem to contribute to the syndrome to different degrees: increased ovarian and/or adrenal androgen

Polycystic ovary syndrome (PCOS) typically manifests during the reproductive period, and no information is available on the prevalence of pelvic floor dysfunction (and